ATE192040T1 - Wirkstoff gegen arteriosklerose - Google Patents
Wirkstoff gegen arterioskleroseInfo
- Publication number
- ATE192040T1 ATE192040T1 AT95909975T AT95909975T ATE192040T1 AT E192040 T1 ATE192040 T1 AT E192040T1 AT 95909975 T AT95909975 T AT 95909975T AT 95909975 T AT95909975 T AT 95909975T AT E192040 T1 ATE192040 T1 AT E192040T1
- Authority
- AT
- Austria
- Prior art keywords
- active ingredients
- proliferation
- smooth muscle
- muscle cells
- arteriosclerosis
- Prior art date
Links
- 206010003210 Arteriosclerosis Diseases 0.000 title abstract 2
- 208000011775 arteriosclerosis disease Diseases 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title 1
- 230000035755 proliferation Effects 0.000 abstract 2
- 210000004509 vascular smooth muscle cell Anatomy 0.000 abstract 2
- DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical compound O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 abstract 1
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11914694 | 1994-05-31 | ||
| PCT/JP1995/000277 WO1995032714A1 (en) | 1994-05-31 | 1995-02-24 | Arteriosclerosis depressant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE192040T1 true ATE192040T1 (de) | 2000-05-15 |
Family
ID=14754063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95909975T ATE192040T1 (de) | 1994-05-31 | 1995-02-24 | Wirkstoff gegen arteriosklerose |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5840741A (de) |
| EP (1) | EP0766963B1 (de) |
| KR (1) | KR970703147A (de) |
| AT (1) | ATE192040T1 (de) |
| AU (1) | AU702727B2 (de) |
| CA (1) | CA2190750A1 (de) |
| DE (1) | DE69516519T2 (de) |
| WO (1) | WO1995032714A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002072580A1 (en) * | 2001-02-26 | 2002-09-19 | Mitsubishi Pharma Corporation | Preventives and/or remedies for kidney diseases and kidney failure |
| US20070225301A1 (en) * | 2006-02-13 | 2007-09-27 | Astion Inflammation Aps | Treatment of acne and other diseases |
| MX2009006507A (es) * | 2006-12-18 | 2009-08-18 | Cardoz Ab | Nueva combinacion para usarse en el tratamiento de trastornos inflamatorios. |
| ES2395120T3 (es) * | 2006-12-20 | 2013-02-08 | Cardoz Ab | Combinación de pemirolast y ramotrobán para su uso en el tratamiento de transtornos inflamatorios |
| WO2009007679A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist |
| WO2009007675A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist |
| CA2693628A1 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | New combination for use in the treatment of imflammatory disorders |
| WO2009007680A2 (en) | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combinations comprising a mast cell inhibitor and a statin for use in the treatment of inflammatory disorders |
| DE102014222804B4 (de) | 2014-11-07 | 2023-12-28 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung und Verfahren zum Bestimmen einer Wandschubspannung und System zur Erkennung von Arteriosklerose |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH9305A (en) * | 1970-05-21 | 1975-08-18 | H Hess | Trialkoxy quinazolines |
| JP3116970B2 (ja) * | 1991-06-12 | 2000-12-11 | 三菱東京製薬株式会社 | ペミロラストカリウムの徐放性製剤 |
-
1995
- 1995-02-24 CA CA002190750A patent/CA2190750A1/en not_active Abandoned
- 1995-02-24 AT AT95909975T patent/ATE192040T1/de not_active IP Right Cessation
- 1995-02-24 KR KR1019960706787A patent/KR970703147A/ko not_active Withdrawn
- 1995-02-24 AU AU18239/95A patent/AU702727B2/en not_active Ceased
- 1995-02-24 WO PCT/JP1995/000277 patent/WO1995032714A1/ja not_active Ceased
- 1995-02-24 EP EP95909975A patent/EP0766963B1/de not_active Expired - Lifetime
- 1995-02-24 DE DE69516519T patent/DE69516519T2/de not_active Expired - Fee Related
- 1995-02-24 US US08/737,680 patent/US5840741A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69516519D1 (de) | 2000-05-31 |
| AU1823995A (en) | 1995-12-21 |
| EP0766963B1 (de) | 2000-04-26 |
| EP0766963A4 (de) | 1997-10-29 |
| EP0766963A1 (de) | 1997-04-09 |
| US5840741A (en) | 1998-11-24 |
| KR970703147A (ko) | 1997-07-03 |
| CA2190750A1 (en) | 1995-12-07 |
| DE69516519T2 (de) | 2000-10-12 |
| AU702727B2 (en) | 1999-03-04 |
| WO1995032714A1 (en) | 1995-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE370138T1 (de) | Neue imidazopyridine und ihre verwendung | |
| MY107341A (en) | Novel hydroxamic acid and n-hydroxyurea derivatives and their use | |
| DE69410121D1 (en) | Dihydro pyrazolopyrrole | |
| TR199801642T2 (xx) | Tedavide faydal� olan karbamik asitlerin azabisiklik esterleri. | |
| EP0939627A4 (de) | Pentafluorobenzensulfonamide und analoge | |
| TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
| SE9604786D0 (sv) | New compounds | |
| DE69519385D1 (de) | Chinazolinon-arzneimittel sowie deren verwendung | |
| NZ513096A (en) | Compositions for treating inflammatory response | |
| TR199902495T2 (xx) | Bile�imler. | |
| IS7839A (is) | 4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar | |
| ATE161531T1 (de) | Acridine-1,8-dionderivate als therapeutisches mittel | |
| ATE192040T1 (de) | Wirkstoff gegen arteriosklerose | |
| DE69223736D1 (de) | Acridine-1,8-Dionderivate als therapeutisches Mittel | |
| MY133785A (en) | Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias | |
| CA2386685A1 (en) | Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases | |
| ATE297926T1 (de) | Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen | |
| DE69103773D1 (de) | Derivate von hydroxaminsäure die lipoxygenase hemmen. | |
| DE69402004D1 (de) | Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen | |
| BR9808546A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições do ser humano, tratar ou reduzir o risco de doença inflamatória e o risco da dor em uma pessoa que sofre, ou em risco, da dita doença e para a preparação do composto | |
| EP1325918A4 (de) | Herzmuskelzellen-apoptose hemmstoffe und behandlung/vorbeugung von herzkrankheiten | |
| SE9802650D0 (sv) | Compounds | |
| ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |